Paper33548843
Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis.
Wang X and 9 others. Thromb Res, 2021. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis. Papers, record 33548843. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33548843
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Thrombosis | Major topic |
| Venous Thrombosis | Major topic |
| Animals | |
| Blood Platelets | |
| Humans | |
| Membrane Glycoproteins | |
| Mice | |
| Platelet Activation |
Source PubMed
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42598555 | Molecular control of platelet extravasation into tumors and its impact on tumor growth. | Blood Vessel Thromb Hemost | 2026 | https://conductscience.org/library/papers/42598555 | PubMed |
| 42319679 | Platelet-Prostate cancer crosstalk driving disparities and therapeutic vulnerabilities. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42319679 | PubMed |
| 42160758 | Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities. | Blood Adv | 2026 | https://conductscience.org/library/papers/42160758 | PubMed |
| 42122282 | Breast Cancer-Associated Venous Thromboembolism: Risk Factors, Mechanisms, and Clinical Management. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122282 | PubMed |
| 41097671 | The Presence of Neutrophil Extracellular Traps (NETs) in Brain Tumor Vessels Is Linked to Platelet Aggregates and Podoplanin in the Tumor Microenvironment. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097671 | PubMed |
| 40766876 | Podoplanin and microthrombi in lung injury. | Blood Vessel Thromb Hemost | 2025 | https://conductscience.org/library/papers/40766876 | PubMed |
| 40741180 | The regulation of cancer-associated thrombosis by podoplanin. | Thromb Update | 2024 | https://conductscience.org/library/papers/40741180 | PubMed |
| 39852571 | From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery. | J Funct Biomater | 2025 | https://conductscience.org/library/papers/39852571 | PubMed |
| 39682237 | Role of Podoplanin (PDPN) in Advancing the Progression and Metastasis of Glioblastoma Multiforme (GBM). | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682237 | PubMed |
| 39457539 | Comprehensive Analysis of a Platelet- and Coagulation-Related Prognostic Gene Signature Identifies CYP19A1 as a Key Tumorigenic Driver of Colorectal Cancer. | Biomedicines | 2024 | https://conductscience.org/library/papers/39457539 | PubMed |
| 39370518 | Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication. | J Nanobiotechnology | 2024 | https://conductscience.org/library/papers/39370518 | PubMed |
| 38893201 | Cancer-Associated Thrombosis: Pathophysiology, Laboratory Assessment, and Current Guidelines. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893201 | PubMed |
| 38504248 | C-type lectin-like receptor 2: roles and drug target. | Thromb J | 2024 | https://conductscience.org/library/papers/38504248 | PubMed |
| 38152726 | Cancer-Associated Thrombosis: Epidemiology, Pathophysiological Mechanisms, Treatment, and Risk Assessment. | Clin Med Insights Oncol | 2023 | https://conductscience.org/library/papers/38152726 | PubMed |
| 38040850 | The dynamic role of platelets in cancer progression and their therapeutic implications. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/38040850 | PubMed |
| 37122533 | Mechanisms of cancer-associated thrombosis. | Res Pract Thromb Haemost | 2023 | https://conductscience.org/library/papers/37122533 | PubMed |
| 37100086 | Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/37100086 | PubMed |
| 36970507 | Podoplanin: A potential therapeutic target for thrombotic diseases. | Front Neurol | 2023 | https://conductscience.org/library/papers/36970507 | PubMed |
| 36652166 | The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis. | Cell Oncol (Dordr) | 2023 | https://conductscience.org/library/papers/36652166 | PubMed |
| 36446819 | Multi-omics peripheral and core regions of cancer. | NPJ Syst Biol Appl | 2022 | https://conductscience.org/library/papers/36446819 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CLEC1B | 51266 | PubTator's text mining | https://conductscience.org/library/genes/51266 | NCBI Gene |
| PDPN | 10630 | PubTator's text mining | https://conductscience.org/library/genes/10630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33548843
GET https://conductscience.org/api/papers/v1/33548843/cited_by?page=2